Genetic polymorphisms predicting the outcome of bone marrow transplants.
about
Prediction of graft-versus-host disease in humans by donor gene-expression profilingIdentification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Expression profiling of major histocompatibility and natural killer complex genes reveals candidates for controlling risk of graft versus host diseaseAssociation of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donorCytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience.Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationGenetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.Hematopoietic cell transplantation for Crohn's disease; is it time?Nucleotide oligomerization domain 2 polymorphisms in patients with intestinal failure.IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantationImpact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation.The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation.Pathophysiology of acute graft-versus-host disease: recent advances.NOD2/CARD15 disease associations other than Crohn's disease.Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment.Advances in the treatment of acute graft-versus-host disease.The role of stem cell transplantation in inflammatory bowel disease.NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignanciesAcute graft-versus-host disease: are we close to bringing the bench to the bedside?Immunoregulatory gene polymorphisms and graft-versus-host disease.Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation.Immunology of hematopoietic stem cell transplant.Hematopoietic stem cell transplantation and cellular therapy.Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease.Predicting survival using clinical risk scores and non-HLA immunogenetics.Cytokine gene polymorphism and graft-versus-host disease: a survey in Iranian bone marrow transplanted patients.RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase.A polymorphism in the TYMP gene is associated with the outcome of HLA-identical sibling allogeneic stem cell transplantation.A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT.Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation.Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis.DAAM2 polymorphism is closely related to the clinical outcomes of allogeneic hematopoietic stem cell transplantation.Distribution of 22 cytokine gene polymorphisms in the healthy Czech population.Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients
P2860
Q21092376-C342AF28-DDF9-4135-812B-FE636DD23D32Q28080914-747A9EA7-42F3-4C9E-8D50-D6B4CA898847Q28743195-33C2501F-F3D6-4538-B90F-81D156E7B94AQ33437907-1079F4CE-BB04-4383-AB9A-8531698902F5Q33577465-C219F577-37F5-462A-A8F1-AAC5B41F5786Q33758318-97CEABFD-ED82-49A5-A906-D2EA9B46DD82Q34008970-3E6461A5-6625-4ACD-AC0E-582CE9EDF826Q34017756-D01E1C9B-A17A-4DE5-AA8E-B386CAF913ACQ34313205-99E02C94-B0E3-4FB5-9111-A245D1AF813DQ34481457-9677E6EF-4565-4DB2-B86A-393244D1982EQ35564082-5A49BB86-F554-4001-AC87-0188C059B6E9Q35809966-78B6DA2C-BA43-4AAF-B4FF-691BDA87ECB9Q36156559-96071EE6-F508-4653-80C2-5F7D486B2A19Q36700677-E69545F5-178F-44C3-B2AC-B9A330585016Q36715943-F26AD29D-E9A2-4D79-AFE3-511EC49A0ABFQ36861714-973EAFC3-08BF-4EB2-9A0D-71B12BABE00EQ37191057-C97AEF92-DA4B-480B-9C74-644B1B2D7094Q37311051-678A43C7-B81A-4160-9B6A-116FEC076667Q37369943-E96199CE-0CFC-41C2-B6BA-619F499F381EQ37402799-C3FE58C3-D5D0-4D5E-9D2A-53F4006F2EBCQ37755281-FDD2CBDC-A6B2-40A0-BDB0-A2D1D32B925FQ37810124-EB3E8931-B383-4AFF-971A-46D31793853DQ38258161-1056AADC-478B-4DFD-88D2-D86893B66BB8Q39216720-E66193DC-948F-42FB-9FA0-15A9CA2F76A8Q39593867-27036BF3-7588-4D9E-9702-DE81866C8FBDQ40692598-53D5FF24-7A24-48FB-9B3B-E14EFF4EA392Q43441667-453E7F44-14CA-448F-A0A9-5C7D96EEFBDBQ43809862-8BC4AB95-4BFD-4772-807E-A17FCB511B02Q44540319-35B2943B-483F-4936-B378-DAF7799064BAQ45192061-7DFA2419-0324-4872-9140-1DBA92F74B28Q46031355-A31E37A3-6376-4EB4-8560-C85F37F21001Q46249991-40AC0AC6-5451-4E17-9DCD-1EB6854A6294Q46503118-D4F43197-4C78-4068-A3AC-F2503750E1C2Q47954841-925363BC-251B-4923-8BF2-4B2DE3DDB8AEQ49645938-6B7E0D9A-61AC-4A9C-AC37-0C79078994C4Q50976983-4AF857CE-668B-412A-B5F7-778F002F5D6DQ51546025-FA9B8D16-BD61-4D6A-B1F5-4D147BB1DA32Q54588395-A8A23C07-6B5A-4749-AEBA-B4E3DC108B19Q56897193-239A4AE6-4047-4502-994E-C469A81083AB
P2860
Genetic polymorphisms predicting the outcome of bone marrow transplants.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genetic polymorphisms predicting the outcome of bone marrow transplants.
@ast
Genetic polymorphisms predicting the outcome of bone marrow transplants.
@en
type
label
Genetic polymorphisms predicting the outcome of bone marrow transplants.
@ast
Genetic polymorphisms predicting the outcome of bone marrow transplants.
@en
prefLabel
Genetic polymorphisms predicting the outcome of bone marrow transplants.
@ast
Genetic polymorphisms predicting the outcome of bone marrow transplants.
@en
P2093
P2860
P1476
Genetic polymorphisms predicting the outcome of bone marrow transplants.
@en
P2093
Anne M Dickinson
Ernst Holler
Eurobank members
Peter G Middleton
Vanderson Rocha
P2860
P304
P356
10.1111/J.1365-2141.2004.05216.X
P407
P577
2004-12-01T00:00:00Z